Morphologic and Microvascular Differences Between Macular Neovascularization With and Without Subretinal Fibrosis
- PMID: 34851359
- PMCID: PMC8648059
- DOI: 10.1167/tvst.10.14.1
Morphologic and Microvascular Differences Between Macular Neovascularization With and Without Subretinal Fibrosis
Abstract
Purpose: To evaluate morphologic and microvascular differences between eyes with and without subretinal fibrosis (SF) caused by neovascular age-related macular degeneration (nAMD).
Methods: Patients with nAMD with a minimum history of 12 months of anti-VEGF treatment were prospectively included in this cross-sectional study. Patients were imaged using standard imaging, swept-source optical coherence tomography angiography for quantitative microvascular analysis and polarization-sensitive OCT as an ancillary method for automated SF segmentation. The presence of reticular pseudodrusen, hyperreflective foci (HRF), and outer retinal tubulation (ORT) were also evaluated.
Results: Sixty eyes of 60 participants (37 female) with nAMD and a mean 3.1 (±2.7)-year history of anti-VEGF treatment were included, 20 (33%) of which were diagnosed with SF. Eyes with SF had a higher prevalence of ORT (P < 0.001) and a lower prevalence of HRF (P = 0.004) than eyes without SF. Fifty eyes were analyzed quantitatively for microvascular biomarkers. Eyes with SF had a larger greatest vascular caliber (P = 0.001) and greatest linear diameter (P = 0.042), a larger microvascular neovascularization (MNV) area (P = 0.026), larger vessel area (P = 0.037), higher number of vessel junctions (P = 0.025), longer total vessel length (P = 0.027), higher number of vessel endpoints (P = 0.007), and higher endpoint density (P = 0.047).
Conclusions: This multimodal imaging approach demonstrated in vivo microvascular and morphological differences in eyes with and without SF. Eyes with SF tend to have larger MNV lesions with thicker vessels and are often associated with the presence of ORT.
Translational relevance: This study points out imaging biomarkers in patients with SF, which may help identifying high-risk patients.
Conflict of interest statement
Disclosure:
Figures



Similar articles
-
Analysis of factors affecting prognosis of the visual acuity and baseline risk factors for subretinal fibrosis in neovascular age-related macular degeneration patients.Front Med (Lausanne). 2024 Nov 28;11:1451726. doi: 10.3389/fmed.2024.1451726. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39669991 Free PMC article.
-
Baseline predictors for subretinal fibrosis in neovascular age-related macular degeneration.Sci Rep. 2022 Jan 7;12(1):88. doi: 10.1038/s41598-021-03716-8. Sci Rep. 2022. PMID: 34996934 Free PMC article.
-
REGRESSION OF TYPE 2 NEOVASCULARIZATION INTO A TYPE 1 PATTERN AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.Retina. 2017 Feb;37(2):222-233. doi: 10.1097/IAE.0000000000001279. Retina. 2017. PMID: 27627752
-
OUTER RETINAL TUBULATION MAY RESULT FROM FIBROSED TYPE 2 NEOVASCULARIZATION: Clinical Observations and Model of Pathogenesis.Retina. 2021 Sep 1;41(9):1930-1939. doi: 10.1097/IAE.0000000000003127. Retina. 2021. PMID: 33492078 Free PMC article.
-
Quantitative Optical Coherence Tomography Angiography Parameters in Type 1 Macular Neovascularization Secondary to Age-Related Macular Degeneration.Transl Vis Sci Technol. 2020 Aug 31;9(9):48. doi: 10.1167/tvst.9.9.48. eCollection 2020 Aug. Transl Vis Sci Technol. 2020. PMID: 32934898 Free PMC article.
Cited by
-
Prediction of the short-term efficacy of anti-VEGF therapy for neovascular age-related macular degeneration using optical coherence tomography angiography.Eye Vis (Lond). 2022 May 1;9(1):16. doi: 10.1186/s40662-022-00287-1. Eye Vis (Lond). 2022. PMID: 35505390 Free PMC article.
-
Imaging biomarkers and artificial intelligence for diagnosis, prediction, and therapy of macular fibrosis in age-related macular degeneration: Narrative review and future directions.Graefes Arch Clin Exp Ophthalmol. 2025 Jul;263(7):1789-1800. doi: 10.1007/s00417-025-06790-0. Epub 2025 Mar 10. Graefes Arch Clin Exp Ophthalmol. 2025. PMID: 40059223 Free PMC article. Review.
-
Structure-Function Correlation of Retinal Fibrosis in Eyes with Neovascular Age-Related Macular Degeneration.J Clin Med. 2024 Feb 14;13(4):1074. doi: 10.3390/jcm13041074. J Clin Med. 2024. PMID: 38398387 Free PMC article.
References
-
- Cheung CMG, Grewal DS, Teo KYC, et al. .. The Evolution of Fibrosis and Atrophy and Their Relationship with Visual Outcomes in Asian Persons with Neovascular Age-Related Macular Degeneration. Ophthalmol Retina. 2019; 3: 1045–1055. - PubMed
-
- Bhisitkul RB, Mendes TS, Rofagha S, et al. .. Macular atrophy progression and 7-year vision outcomes in subjects from the ANCHOR, MARINA, and HORIZON studies: the SEVEN-UP study. Am J Ophthalmol. 2015; 159: 915–924.e2. - PubMed
-
- Rofagha S, Bhisitkul RB, Boyer DS, Sadda SR, Zhang K, Group S-US. Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP). Ophthalmology. 2013; 120: 2292–2299. - PubMed
-
- Bloch SB, Lund-Andersen H, Sander B, Larsen M.. Subfoveal fibrosis in eyes with neovascular age-related macular degeneration treated with intravitreal ranibizumab. Am J Ophthalmol. 2013; 156: 116–124.e1. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources